Requires health benefit plans to cover biomarker testing for diagnosis and treatment.
This bill mandates that all health benefit plans, including Medicaid, cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition if supported by medical and scientific evidence. Biomarker testing includes various types of genomic and molecular sequencing. The bill defines biomarker and biomarker testing and requires health benefit plans to update their medical policies and coverage guidelines accordingly.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.